Results were similar in REACH and REACH‐2, although they did not reach statistical significance in REACH‐2 (Table S1 ). 3.3 Post‐progression survival Post‐progression survival by radiographic progression patterns was examined in 398 patients in REACH, 205 patients in REACH‐2 and 386 patients in the pooled population; 22 patients were excluded because of loss to follow‐up or withdrawal of consent for follow‐up after progression.
← all excerpts
Pattern of progression in advanced hepatocellular carcinoma treated with ramucirumab.
1
—
—